Treating stubborn facial pain
Part of Pain clinical trials.
This trial tests a treatment for unusual facial pain that doesn't get better with standard care. It may help if you have facial pain and no psychiatric condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pain in your face
- You do not have a psychiatric disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.
This trial tests a new cognitive-behavioral therapy (a type of talk therapy) for people with chronic orofacial pain – pain in the face, mouth, or jaw that has lasted for months. The goal is to learn skills to help manage pain and improve quality of life.
This trial tests if a non-invasive brain stimulation technique (called TMS or tDCS) can help reduce long-lasting pain in the face, jaw, or mouth. It's for people who have tried other treatments without enough relief.
This study compares two pain-relieving medicines given through an IV to see which works better for people with difficult-to-treat face or mouth pain. It may help you if other treatments have not worked.
This study uses brain scans (MRI) to better understand persistent pain in the face or mouth (PIFP) compared to people without pain. If you join, you'll have an MRI and possibly some mild stimulation to help researchers learn more about the condition.
This study tests a device implanted in the brain that may reduce long-lasting nerve pain that has not improved with other treatments. It could help people with pain after nerve injury, stroke, or other conditions.
Hear when a new Facial Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.